Renal denervation for hypertension: cross-country cost-effectiveness insights from mainland China, Japan, and Thailand

Abstract Background Renal denervation (RDN) has been introduced as a novel non-pharmacological intervention for patients with hypertension that is poorly controlled by pharmacological means. Our study aims to evaluate the cost-effectiveness of the Netrod RDN treatment plus antihypertensives compared...

Full description

Saved in:
Bibliographic Details
Main Authors: Dai Lian, Yue Suo, Ruoyan Gai, Ning li, Yunfeng Ren, Dunming Xiao, Jiaxin Zhao, Mingdong Zhang, Shimeng Liu, Yingyao Chen
Format: Article
Language:English
Published: BMC 2025-08-01
Series:Health Economics Review
Subjects:
Online Access:https://doi.org/10.1186/s13561-025-00669-w
Tags: Add Tag
No Tags, Be the first to tag this record!